Open access
Open access
Powered by Google Translator Translator

Rheumatology

USPSTF Statement: Insufficient evidence to recommend Vitamin D deficiency screening

14 Apr, 2021 | 01:47h | UTC

Vitamin D Deficiency in Adults: Screening – U.S. Preventive Services Task Force

Evidence Report: Screening for Vitamin D Deficiency in Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force

Editorial: The USPSTF 2021 Recommendations on Screening for Asymptomatic Vitamin D Deficiency in Adults: The Challenge for Clinicians Continues – JAMA AND Why USPSTF Still Finds Insufficient Evidence to Support Screening for Vitamin D Deficiency – JAMA Network Open

JAMA Patient Page: Screening for Vitamin D Deficiency in Adults

 


NICE Guideline: Assessment and Management of Chronic Pain in Over 16s

8 Apr, 2021 | 08:54h | UTC

Chronic pain (primary and secondary) in over 16s: assessment of all chronic pain and management of chronic primary pain – National Institute for Health and Care Excellence

News release: NICE recommends range of effective treatments for people with chronic primary pain and calls on healthcare professionals to recognise and treat a person’s pain as valid and unique to them

 


RCT: Upadacitinib vs. Adalimumab for Psoriatic Arthritis

5 Apr, 2021 | 00:57h | UTC

Trial of Upadacitinib and Adalimumab for Psoriatic Arthritis – New England Journal of Medicine (link to abstract – $ for full-text)

 


RCT: Surgical microdiscectomy versus transforaminal epidural steroid injection in patients with sciatica secondary to herniated lumbar disc

25 Mar, 2021 | 08:12h | UTC

Surgical microdiscectomy versus transforaminal epidural steroid injection in patients with sciatica secondary to herniated lumbar disc (NERVES): a phase 3, multicentre, open-label, randomised controlled trial and economic evaluation – The Lancet Rheumatology

 

Commentary on Twitter

 


Systematic review: Interventions for cutaneous disease in systemic lupus erythematosus

17 Mar, 2021 | 02:30h | UTC

Interventions for cutaneous disease in systemic lupus erythematosus – Cochrane Library

 


RCT: Little benefit from osteopathic manipulative treatment on activity limitations in patients with nonspecific subacute and chronic low back pain

16 Mar, 2021 | 01:39h | UTC

Effect of Osteopathic Manipulative Treatment vs Sham Treatment on Activity Limitations in Patients With Nonspecific Subacute and Chronic Low Back Pain: A Randomized Clinical Trial – JAMA Internal Medicine (free for a limited period)

Visual abstract: Effect of Osteopathic Manipulative Treatment vs Sham Treatment on Activity Limitations in Patients With Nonspecific Subacute and Chronic Low Back Pain

 


RCT: Efficacy of a combination of conservative therapies vs. an education comparator on clinical outcomes in thumb base osteoarthritis

14 Mar, 2021 | 20:13h | UTC

Efficacy of a Combination of Conservative Therapies vs an Education Comparator on Clinical Outcomes in Thumb Base Osteoarthritis: A Randomized Clinical Trial – JAMA Internal Medicine (free for a limited period)

Commentary: Mix of treatments could be way to restore hand function in thumb-base osteoarthritis – University of Sydney

 

Commentary on Twitter

 


Cardiovascular disease risk in immune-mediated inflammatory diseases: recommendations for clinical practice

7 Mar, 2021 | 19:20h | UTC

Cardiovascular disease risk in immune-mediated inflammatory diseases: recommendations for clinical practice – Heart

 


RCT: Rituximab vs. tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis

7 Mar, 2021 | 19:06h | UTC

Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trial – The Lancet

Commentary: Precision medicine in rheumatology: are we getting closer? – The Lancet

 

Commentary on Twitter

 


Guideline: Epidural interventions in the management of chronic spinal pain

5 Mar, 2021 | 08:09h | UTC

Epidural Interventions in the Management of Chronic Spinal Pain: American Society of Interventional Pain Physicians (ASIPP) Comprehensive Evidence-Based Guidelines – Pain Physician

 


Systematic Review: Belimumab for systemic lupus erythematosus

2 Mar, 2021 | 01:11h | UTC

Belimumab for systemic lupus erythematosus – Cochrane Library

Summary: What are the benefits and risks of belimumab for treating systemic lupus erythematosus (an autoimmune disease that affects the whole body)? – Cochrane Library

 


Joint Statement: Hydroxychloroquine use with respect to retinal toxicity

28 Feb, 2021 | 20:41h | UTC

ACR, AAD, RDS, and AAO 2020 Joint Statement on Hydroxychloroquine Use with Respect to Retinal Toxicity – Arthritis & Rheumatism

Commentary: Societies Agree on Eye Safety for HCQ – MedPage Today (free registration required) AND ACR, medical societies reach consensus on hydroxychloroquine retinopathy – Healio (free registration required)

 

Commentary on Twitter

 


RCT: Effect of telephone cognitive behavioral therapy for insomnia in older adults with osteoarthritis pain

25 Feb, 2021 | 08:29h | UTC

Effect of Telephone Cognitive Behavioral Therapy for Insomnia in Older Adults With Osteoarthritis Pain: A Randomized Clinical Trial – JAMA Internal Medicine

Commentary: Effective treatment for insomnia delivered in a few short phone calls – University of Washington

 


Musculoskeletal involvement of COVID-19: review of imaging

24 Feb, 2021 | 02:43h | UTC

Musculoskeletal involvement of COVID-19: review of imaging – Skeletal Radiology

Commentaries: Radiological images confirm ‘COVID-19 can cause the body to attack itself’ – Northwestern University AND Imaging highlights COVID-19’s MSK manifestations – AuntMinnie

 


RCT: Avacopan for the treatment of ANCA-associated vasculitis

18 Feb, 2021 | 02:50h | UTC

Avacopan for the Treatment of ANCA-Associated Vasculitis – New England Journal of Medicine (link to abstract – $ for full-text)

 


RCT: Among patients with knee osteoarthritis, high-intensity strength training was not associated with better outcomes compared with low-intensity strength training or an attention control

17 Feb, 2021 | 01:24h | UTC

Effect of High-Intensity Strength Training on Knee Pain and Knee Joint Compressive Forces Among Adults With Knee Osteoarthritis: The START Randomized Clinical Trial – JAMA

Commentary: No Benefit from High-Intensity Strength Training for Knee Osteoarthritis – NEJM Journal Watch

 

Commentary on Twitter

 


Cohort study: Risk factors associated with transition from acute to chronic low back pain

17 Feb, 2021 | 01:21h | UTC

Risk Factors Associated With Transition From Acute to Chronic Low Back Pain in US Patients Seeking Primary Care – JAMA Network Open

 

Commentary on Twitter

 


Review: Diagnosis and treatment of hip and knee osteoarthritis

16 Feb, 2021 | 02:05h | UTC

Diagnosis and Treatment of Hip and Knee Osteoarthritis: A Review – JAMA (free or a limited period)

 


Effectiveness of telerehabilitation in physical therapy: A rapid overview

16 Feb, 2021 | 01:53h | UTC

Effectiveness of telerehabilitation in physical therapy: A rapid overview – Physical Therapy

 


FDA Drug Safety Communication: Initial safety trial results find Tofacitinib, used for arthritis and ulcerative colitis, may increase the risk of serious heart-related problems and cancer

9 Feb, 2021 | 01:00h | UTC

Xeljanz, Xeljanz XR (tofacitinib): Drug Safety Communication – Initial Safety Trial Results Find Increased Risk of Serious Heart-related Problems and Cancer with Arthritis and Ulcerative Colitis Medicine – U.S. Food & Drug Administration

Commentary: Arthritis, Colitis Drug Tied to Heart-Related Problems and Cancer – NEJM Journal Watch

 


Randomized trial: Effect of diacerein vs. celecoxib on symptoms in knee osteoarthritis

29 Jan, 2021 | 01:30h | UTC

An international, multicentre, double-blind, randomized study (DISSCO): effect of diacerein vs celecoxib on symptoms in knee osteoarthritis – Rheumatology

Commentary: Noninferiority of diacerein to celecoxib demonstrated for knee OA pain – Medwire News

 


Cohort study: Association of maternal autoimmune disease with Attention-Deficit/Hyperactivity Disorder in children

26 Jan, 2021 | 00:40h | UTC

Association of Maternal Autoimmune Disease With Attention-Deficit/Hyperactivity Disorder in Children – JAMA Pediatrics (free for a limited period)

Editorial: More Evidence Linking Autoimmune Diseases to Attention-Deficit/Hyperactivity Disorder (free for a limited period)

Commentary: Risk of ADHD may increase if expectant mother has autoimmune disorder, study says – CNN AND Study Suggests Maternal Autoimmune Disease Linked to ADHD in Children – Physician’s Weekly AND Maternal Autoimmune Diseases Linked to ADHD in Children – NEJM Journal Watch

 

Commentary on Twitter

 


Meta-analysis: Multiple intra-articular corticosteroid injections are no better than placebo for osteoarthritis pain

25 Jan, 2021 | 00:56h | UTC

Efficacy and safety of multiple intra-articular corticosteroid injections for osteoarthritis—a systematic review and meta-analysis of randomized controlled trials and observational studies – Rheumatology

 


Meta-analysis: Little benefit from antidepressants for the treatment of back pain and osteoarthritis

22 Jan, 2021 | 08:27h | UTC

Efficacy and safety of antidepressants for the treatment of back pain and osteoarthritis: systematic review and meta-analysis – The BMJ

Commentary: Do antidepressants help back pain and osteoarthritis? – University of Sidney AND Antidepressants largely ineffective for back pain and osteoarthritis – The BMJ

Editorial: Antidepressants for musculoskeletal pain – The BMJ

 

Commentary on Twitter

 


Pharmacological and non-pharmacological therapeutic strategies in difficult-to-treat rheumatoid arthritis: a systematic literature review informing the EULAR recommendations for the management of difficult-to-treat rheumatoid arthritis

22 Jan, 2021 | 08:08h | UTC

Pharmacological and non-pharmacological therapeutic strategies in difficult-to-treat rheumatoid arthritis: a systematic literature review informing the EULAR recommendations for the management of difficult-to-treat rheumatoid arthritis – RMD Open

 


Stay Updated in Your Specialty

No spam, just news.